# Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer Patients

> **NCT02967341** · PHASE4 · UNKNOWN · sponsor: **Universitair Ziekenhuis Brussel** · enrollment: 15 (estimated)

## Conditions studied

- Childhood Cancer
- Neutropenia

## Interventions

- **OTHER:** Ciprofloxacin administration

## Key facts

- **NCT ID:** NCT02967341
- **Lead sponsor:** Universitair Ziekenhuis Brussel
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-03
- **Primary completion:** 2017-03
- **Final completion:** 2017-03
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2016-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02967341

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02967341, "Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer Patients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02967341. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*